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ABSTRACT
The bovine supramammary lymph node, located on the dorso-caudal surface of
the udder, is a protein rich organ that is discarded on a regular basis during slaughter.
Experiments were conducted to evaluate whether or not the lymph node extract could be
used as a substitute for bovine growth serum in cell media. Two different preparations of
lymph node extract were made and tested. Three different cell lines (MDA-MB-435,
MAC-T, and 1C6) were used in assays to evaluate the lymph node extract as a
supplement.

The first extract yielded a protein concentration of 3.0 mg/ml (heat

inactivated) and the second extract contained 27 mg/ml (heat inactivated). MTT and
CyQuant assays were used to determine cell viability and proliferation, respectively, in
the presence of lymph node extract. Both heat inactivated preparations supported cell
growth as well as or better than BGS following a two day serum starvation phase in
culture. The second lymph node preparation provided a stimulatory effect following
serum starvation on all three cell lines at 10 and 20% supplementation. Direct culture of
cells into 10% lymph node extract did not support cell growth as expected. However,
gradual adaptation process with lymph node supplementation into media maintained cell
growth up to a full 10% extract. Once cells were trypsinized and re-seeded with the 10%
lymph node extract they were unable to re-adhere, leaving them detached, and eventually
appeared dead. Analysis of DNA revealed any apparent cell death visually observed was
not due to apoptosis. The stimulatory effect at 10 and 20%, illustrated by the CyQuant

assays, may provide explanation as to why adherence was not achieved in culture. These
higher protein concentrations may present an over abundance of mitogenic protein/factors
resulting in over-stimulation of cells.

Lowering the protein concentration, or

fractionating the extract, could possibly provide a better environment for cells to grow
and adhere in culture. In conclusion, substitution of BGS at 10% dramatically stimulates
cells but does not maintain cell growth in vitro. Further research may prove lower
concentrations can sustain cells in culture by lowering mitogenic protein/factors to substimulatory concentrations.
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1. LITERATURE REVIEW
Cell Culture and Serum Supplementation
The in vitro growth and expansion of animal and plant cells is termed cell culture.
Although the methodology advanced during the first half of the twentieth century, animal
cell culture became imperative in the 1940’s and 1950’s when polio epidemics became
prominent and the need for mammalian cell-based vaccine production was required
(Chaudry, 2004). Through cell culture, large amounts of the poliovirus were grown, and
the polio vaccine was developed and became one of the first products of cultured animal
cells. Later, during the 1970’s, the technique for monoclonal antibody production was
developed, and cell culture then became a more widely practiced methodology (Kohler
and Milstein, 1976). Cell culture has been and is still a very important scientific research
tool today for tissue construction, product testing and embryo propagation. Hence, it is a
vital component of both research and industrial laboratories.
In order to support the growth of cells in culture the proper nutrient components
must be included in cell media. Amino acids, antibiotics, vitamins, as well as a source of
growth factors, are essential for cell survival in culture. Additional factors may be added
to media depending on the type of cell being cultured. An important ingredient for
almost all cell lines is serum. Bovine derived sera are commonly used in cell media
because of the relatively easy access to large volumes of blood at abattoirs. Bovine
growth serum, fetal calf and bovine sera, and bovine serum albumin are all used in cell
culture.

Different growth factors and carrier proteins in bovine serum support and

maintain cell growth.

Fetal bovine serum contains many important proteins that

contribute to nurturing the growth of cells. For example, adult pigment epithelial cells
were treated with three different lots of fetal bovine serum, and then evaluated to
determine whether a difference in cell growth rates would be observed among lots.
Although one lot stimulated a higher cell growth rate, the amount of high abundance
proteins did not discriminate between lots (Zheng et al., 2006).
Major proteins identified in the serum were albumin, transforming growth factorbeta (TGF- β), insulin like growth factor binding protein (IGF-BP), and insulin like
growth factor-II (IGF-II) (Zheng et al., 2006).

IGF-BP-III as well as IGF-II and IGF-I

have also been found in bovine serum albumin preparations (Twigg et al., 2000). IGF-I
and -II have been identified in both adult and fetal bovine sera (Honegger and Humbel,
1986). Albumin also plays an important role in serum. As a carrier protein it has been
suggested to carry cholesterol and fatty acids for membrane synthesis of cells (Washburn
et al., 1978). Additionally, bovine serum contains a complex assortment of different
substances, some of which are still undetermined.
Due to potential interference by certain components of bovine sera on human
tissue cultures, research has been conducted to replace animal-based serum with human
serum albumin (HSA).

Schneider et al. (2003) found that human serum albumin

enhanced insulin production and cell viability of encapsulated rat islets over a period of 3
weeks. As a potential substitute for FBS, a study was conducted with HSA added to
C2C12 myoblast cells and baby hamster kidney (BHK) cells. HSA did not support
viability of BHK cells; however they found that HSA could be used with the C2C12
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cells, but only for a limited time before protein secretion decreased (De Castro, et al.,
2006).
Serum free media are also used in cell culture; although most cell lines require the
addition of purified components obtained from serum. There are also cell lines that
thrive in serum free media. Specifically, Kambe et al. (2000) found that fetal liver cells
stimulated with recombinant human stem cell factor (HSCF) and cultured in a serum free
medium produced more mast cells than fetal liver cells treated with media containing
serum. In this case, serum adversely affected cell development induced by HCSF and
serum free media allowed for greater expansion of mast cells under the influence of
HSCF. Human corneal endothelial cells have also been shown to grow without bovine
serum present in the medium (Bednarz et al., 2001). Although some cell lines are
capable of growth in vitro without serum supplementation, there remain a large number
of important cell lines that require this critical supplement for survival in culture.
Much of what is understood about serum supplementation is anecdotal, but many
cell lines in culture still require the growth supporting effect of bovine serum. Most cells
in an organism rarely come in direct contact with blood plasma; however the use of
serum to grow cells has not been overly questioned. Scientists assume cells need serum
and initially culture cells with serum. Although different serum replacement supplements
are commercially available, serum remains in high demand as an essential ingredient in
media for many cell lines in culture today.
Whether cell culture supplementation includes serum or substitutes, a further
consideration is cost for cell propagation and maintenance. Five hundred ml of heat
inactivated Hyclone BGS costs $96 (Fisher Scientific). The same volume of bovine
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based serum products, replacements for FBS, can cost up to $109 (Fisher Scientific).
Because of the high cost of these supplements, other replacements as well as serum free
media have been introduced into cell culture. A supplemented calf serum, Omni Serum,
has been demonstrated to support growth of cells used to isolate herpes simplex virus in
culture (Johnston and Siegel, 1990).

Omni Serum was able to be used at lower

concentrations than FBS and cell performance was not different. This replacement is
commercially available (Advanced Biotechnologies Inc., Columbia Md.) and costs 31%
less than FBS. Conditioned media is also available for use in cell culture. Leishmania
infantum chagasi was grown in conditioned media that was obtained from cultures of
McCoy cells grown in Eagle's medium supplemented with 5% FCS. After the McCoy
cells grew in the medium, it was considered “conditioned” because of the excretion of
metabolites that are beneficial for the growth and survival of the parasite (Noqueira and
Galati, 2006).
Although alternatives to the different sera are available, different cell lines require
different factors that may not be obtained from sources other than serum. The quest for
less expensive serum replacements will continue. An optimal replacement would include
an abundance of growth promoting factors that can support numerous cell types in
culture.

Considering the presence of interstitial fluid around cells in the tissue

environment, the use of a protein-rich tissue extract may offer an alternate to serum.
Interstitial fluid drains from tissues to enter the lymphatics and become the major fluid
component of lymph. As lymph fluid moves through the lymphatics and lymph nodes,
this fluid becomes enriched with cells and lymph factors (immunoglobulins, complement
proteins, cytokines, chemokines, and growth and differentiation factors) prior to the
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lymph mixing with the blood. Therefore, recovered tissue extracts from lymph nodes
should possess a rich mixture of factors that may support the growth of cells, especially
in culture.

Composition of lymph node

The lymph node is an immunological organ with an abundance of cells such as
dendritic cells, macrophages, T cells, and B cells. The signaling molecules these cells
produce, along with different growth factors potentially present in the lymph node, yield
the lymph node as a protein-rich source.

Lymph nodes are positioned along the

lymphatic vessels throughout the body where lymph passes through them and transports
fluid, cells and foreign antigens; the latter requiring processing in order to induce immune
responses in the lymph node. Antigen presenting cells (primarily dendritic cells) are
picked up from sub-epithelial sites by lymph, which is derived from interstitial fluid, and
delivered to the lymph nodes (Willard-Mack, 2006).
The lymph node itself is described as having three compartments: the cortex,
paracortex and medulla. Each compartment has a role in the overall function of the
lymph node. The basic functional unit of the lymph node is the lymphoid lobule, which
spans all three compartments. The number of lobules depends on the size of the lymph
node; the amount can range from only one to many. Arranged side by side, the lobules
contain follicles in the cortex, deep cortical units in the paracortex, and medullary cords
in medulla. The follicles contain B cells, which when stimulated proliferate within the
follicles to form germinal centers, ultimately transforming the primary follicle to a
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secondary follicle. T cells localize in the paracortex and also proliferate in this area when
stimulated by antigen-major histocompatibility complex presentation by an antigen
presenting cell. The deep cortical unit is a passage for lymphocytes going back and forth
from the T- and B-cell areas. Once B cells are stimulated and produce plasma cells
through affinity maturation in germinal centers, the plasma cells move into the medullary
cords in order to mature and secrete antibodies which are then released into lymph
(Willard-Mack, 2006). In order to communicate with neighboring cells many of the
immunological cells produce and secrete signaling molecules that perform a variety of
growth and differentiation promoting functions. Examples include TGF-β and -α; IL-1, 2, -3, -4, -5, -6, -8, -9, -10, -12, and -13; and interferons.
The framework of the lymph node consists of a reticular meshwork.

This

meshwork is composed of fibroblastic reticular cells (FRC) and their reticular fibers. The
meshwork serves as a migration site for the lymphocytes to adhere to for movement
throughout the lymph node. The FRC are coated with migration ligands (fibronectin) on
their surfaces which assist in the lymphocyte migration. Furthermore, a specific type of
macrophage, termed ‘sinus histiocyte’, attaches onto the meshwork and “catches”
different lymph components such as bacteria, cell debris, red blood cells, and injected
carbon (Willard-Mack, 2006). The fibroblastic reticular cells also secrete fibers which
are composed of collagens type I, III and IV; elastin; entactin; fibronectin; laminin-1;
tenascin; vitronectin; and heparin sulfate (Willard-Mack, 2006).
An understanding of the structure and function of the lymph node allows for a
better understanding of the general cellular components residing within a lymph node
environment. Although all of the proteins in the lymph node have not been characterized,
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many have been isolated and identified. It has been suggested that all proteins found in
plasma are found in lower concentrations in lymph. This is pertinent considering it has
been suggested that the lymph node itself contributes a small volume of high protein
lymph to the efferent lymph (Quin and Shannon, 1977). Many different growth factors
may be present in the lymph node. Lacasse et al. (1996), found that all of the IGF-BP’s
that are present in serum are also in lymph fluid, but have lower binding activities. Other
growth factors such as TGF-β may also be present in lymph nodes. TGF-β is produced by
activated T-helper 1 cells and Natural Killer cells. TGF-β has proliferative effects on a
variety of mesenchymal and epithelial cells. A study by Zou et al. (1996) detected genes
strongly expressed that coded for different cytokines in lymphoid tissues after infection
with Simian Immunodeficiency virus. Proinflammatory cytokines included IL-6, IL-1β,
and TNF-α. IFN-γ, IL-13, IL-4, IL-12, IL-10 and chemokines MIP-1α, MIP-1β, MCP-1,
and RANTES were also expressed (Zou et al. 1996). The different cytokines present in
the lymph node stimulate proliferation, differentiation, antibody production, and
activation of a variety of cells. Cytokines provide a signaling system for the immune
system to inter-cellularly communicate and properly function.

Supramammary lymph node

The bovine supramammary lymph nodes are located on the dorso-caudal surface
of the udder (Bradley et al., 2001). The number and size of the supramammary lymph
nodes varies, with a frequent configuration of one on each side of the udder. Age
however, as well as mastitis history, can dictate the size of the supramammary lymph
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node, with older cows and cows with a history of mastitis tending to have larger lymph
nodes (Bradley et al., 2001). Lymph node anatomy examined ultrasonographically by
Bradley et al. (2001) was consistent with the appearance described for other lymph nodes
in cattle as well as humans.
Infections such as bovine mastitis can cause significant damage to the udder tissue
and affect milk production in the cow. In order to elicit a quick recovery from these
types of infections a rapid immune response is necessary. The supramammary lymph
nodes are the first lymphoid organs that come in contact with antigens during bacterial
invasions of the mammary gland (Watson and Davies, 1985). These lymph nodes, along
with a localized inflammatory response, are crucial to the defense against antigens in the
udder, and play an imperative role in protecting the mammary gland.
Although all of the supramammary lymph node components have not been
characterized, the lymph which passes through this lymph node has been studied.
Watson and Davies (1985) obtained results, from ewes immunized in the hind limb,
indicating that most leukocytes in efferent mammary lymph are derived from the
supramammary lymph nodes. Also, the general components listed in the previous section
are maintained throughout all lymph nodes, thereby giving a general understanding of the
cells and proteins which would constitute the supramammary lymph node.
A study analyzing the flow and content of afferent lymph found that there were
major differences between the afferent lymph and blood plasma of cows (Gorweit et al.,
1993). Specifically, the lymph contained up to ten times less protein, albumin, and
globulin than plasma. Calcium levels in lymph were half that compared to plasma.
Gorweit et al. (1993) found that glucose concentrations were similar between afferent
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mammary lymph and plasma; however, afferent lymph contained 17 times less
cholesterol than blood plasma and half as much triglyceride (Gorweit et al., 1993). A
study by Waller et al. (2003) examined cytokines in afferent and efferent lymph of the
supramammary lymph node after intra-mammary infusion with Escherichia coli
endotoxin which causes mastitis in cows. Neutrophils, IL-8, and TNF-α were found in
both efferent and afferent lymph as soon as 2 hours after infusion. IL-8 plays a primary
role in the recruitment of neutrophils into the bovine mammary gland; therefore, the
presence of IL-8 in the lymph from the supramammary lymph node is important in the
defense against infection of the gland.
Naïve lymphocytes are recruited to lymph nodes through adhesion molecules.
Peripheral node addressin (PNad) and vascular cell adhesion molecule (VCAM-1)
adhesion molecules were found in the supramammary lymph node. PNad was detected in
the lymph node at four different physiological stages in the cow: pregnant, colostral,
lactation, and involution (Hodgkinson et al., 2007). PNad was not found in the mammary
alveolar tissues, suggesting that it is involved in recruitment of lymphocytes to the
supramammary lymph node. Leukocytes form a bridge while binding to PNad via Pselectin, which binds carbohydrate ligands on the leukocytes (Walzog and Gaehtgens,
2000). This binding aids in the recruitment of cells to the lymph node. VCAM-1 was
found in the mammary tissues as well as the lymph node (Hodgkinson et al., 2007).
VCAM-1 functions by mediating leukocyte-endothelial interactions by binding to the
α4/ß1 and the α4/β7-integrins as well as to the ß2-integrins (Walzog and Gaehtgens, 2000).
The bovine mammary gland may also be an important determiner of components
inside the lymph node since draining lymphatics would carry mammary tissue fluids in

9

the lymph. A study in which autologous lymphocytes were infused into the bovine
mammary gland found that the lymphocytes were able to migrate into the supramammary
lymph node (Kimura et al., 2005). The mammary gland is composed of several different
cell types: epithelial cells, myoepithelial cells, fibroblast cells, adipocytes, endothelial
cells, and plasma cells (Lacasse et al., 1996). Growth factors and other proteins produced
and secreted by these cells could drain into the supramammary lymph node. IGF-I and
prostaglandin E2 (PGE2) are two prominent factors found in the mammary gland and are
also present in the lymph from the supramammary lymph node (Lacasse et al., 1996).
Epidermal growth factor, TGF-α and -β are also important effectors of mammary growth
and present in the mammary gland (Plaut, 1993).
The position of the supramammary lymph node provides a rapid immune
response to antigens in the udder. Sordillo et al. (1995) stimulated monocytes from
supramammary lymph nodes and peripheral blood of mid- to late- lactating and
periparturient cows with lipopolysaccharide. Monocytes isolated from lymph nodes
during the periparturient period had significantly higher levels of TNF-α compared to
those from peripheral blood (Sordillo et al., 1995). Ewes vaccinated against S. aureus in
the hind limb (directly primed’ supramammary nodes) (before challenge) had
significantly higher outputs of IgM and IgG2 containing cells in lymph as well as higher
concentrations of IgG1 and IgG2 antibodies compared to controls, brisket immunized,
and lymphadenectomised ewes (Watson and Davies 1985). Opdebeeck and Norcross
(1984) also found that high levels of antibody can be maintained in milk if cows are
vaccinated in the region of the supramammary lymph node with Freund’s incomplete
adjuvant along with staphylococcal and streptococcal antigens. The theme among these
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studies was that the closer the antigen is delivered to the area of the lymph node; the
better the immune response that can be produced. This provides some insight as to why
the lymph node is positioned as it is in the mammary gland.
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2. INTRODUCTION

The bovine supramammary lymph node located on the dorso-caudal surface of the
udder (Bradley et al., 2001) is discarded during meat processing of cows. This proteinrich lymphoid organ is easily recovered during processing when the udder is removed.
The apparent source of bioactive proteins in the lymph node led to the idea of substituting
a lymph node extract for serum in cell culture media. In order to do this, the lymph node
must have the appropriate growth factors to support growth of a variety of cell lines.
Lacasse et al. (1996) reported mitogenic activity of bovine mammary gland
lymph on bovine mammary epithelial cells (MAC-T) and mammary fibroblasts. PGE2,
which has been shown to stimulate proliferation of rodent mammary epithelial cells, was
high in bovine lymph, and when more PGE2 was added to the lymph mitogenic activity
increased (Lacasse et al., 1996).
A study also using MAC-T cells tested the mitogenic effects of mammary tissue
extracts from prepubertal heifers raised to high- or low-rate of gain (Berry et al., 2003).
The mammary tissue extracts from high-fed heifers stimulated less mitogenic activity
compared to the mammary tissue extracts from low-fed heifers. Berry et al. (2003) also
extracted tissue from ovariectomized (OVX) heifers and found there were no differences
in proliferative responses of MAC-Ts between OVX or control mammary tissue extracts.
Weber et al. (1999) showed that mammary extracts from prepubertal heifers stimulated
mammary epithelial cell proliferation much more than heifer serum or IGF-I alone. The
results from these studies collectively show that the bovine mammary gland contains

growth factors for mammary epithelium. IGF-I as well as TGF-α are produced in the
mammary gland and stimulate DNA synthesis of mammary epithelial cells (Weber et al.,
1999). IGF-II is also found in the mammary tissue of ewe lambs. In order to assess how
much influence IGF-I has on cell proliferation, recombinant human insulin like growth
factor binding protein-3 (rhIGFBP-3), which would bind to IGF-I, was added to serum
and extracts, and it ultimately inhibited one third of the DNA synthesis produced by
serum or extracts (Weber et al., 1999). Clearly, IGF-I is an important growth factor for
mammary epithelial cells. Weber et al. (2000) also tested mammary tissue extracts on
bovine primary mammary epithelial cells and investigated whether or not exogenous
growth hormone (GH) or feeding level influenced mitogenic activity.

Five percent

mammary extract stimulated [3H] thymidine incorporation into DNA of more cells than
10% fetal bovine serum or 100 ng/ml of IGF-I. In concurrence with Berry et al. (2003)
high-fed compared to low-fed heifer mammary extracts inhibited [3H] thymidine
incorporation into cultured mammary epithelial cells. On the other hand, when GH was
administered, high-fed compared to low-fed heifers had an increased [3H] thymidine
incorporation into mammary epithelial cells in response to mammary tissue extracts.
Growth hormone treated high-fed heifers also had increased tissue IGF-I levels (Weber et
al., 2000).
Bovine mammary epithelial cells (MAC-T) were used in the present study as
well. A human breast cancer cell line (MDA-MB-435) and a hybridoma line (1C6) were
also used. All three cell types had a common characteristic of adherence in culture. The
MAC-T cells were used because of their bovine origin in the mammary gland, as well as
their general characteristic as an epithelial cell. The MDA-MB-435 cancer cells were
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used for a couple of reasons. As a mammary epithelial cell line they served as a human
comparison to the bovine MAC-T cells. They were also used to determine the response
of a cancer line to the extract. The 1C6 hybridoma cells were used because of their
immunological capacity as well as their general difference in morphology from the
MDA-MB-435 and MAC-T cells.

Because 1C6 cells are a fusion hybridoma of a

myeloma cell and a B cell, components in the lymph node which are naturally present to
communicate with B cells, should theoretically stimulate these cells. The 1C6 cells do
not possess the spreading characteristic that the other two lines present, but these cells do
adhere and maintain a rounded morphology in culture. In order to analyze whether or not
the lymph node extract could be used as a substitute in cell culture media these cell lines
were used. These cells were chosen not only for their individual characteristics, but for
the diversity of cell origin and apparent dependence on either the mammary gland or
lymph node environment.
Rather than using mammary tissue or lymph, as previous studies have tested, we
chose to use only the supramammary lymph node. As an immunological organ this
lymph node is a rich source of a variety of leukocytes, cytokines, and potential growth
factors. Unlike the mammary tissue, the supramammary lymph node is involved in the
capturing and processing of antigens and may be void of infections that may be present in
the udder. This allows assurance that toxins will not be introduced to the cells the extract
is tested on in culture. Along with the possible mitogenic factors in the lymph node, the
recovery and economical aspects were also factors in this study. At this time the udder
along with the supramammary lymph nodes are thrown away as waste during slaughter.
The lymph nodes are very easy to extract allowing one to obtain a large quantity of

15

material for research and potential commercial use. This project is an initial attempt to
understand the effects of the bovine supramammary lymph node extract on cell growth as
a potential cell culture supplement.
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3. MATERIALS AND METHODS
Cell Culture
Three different established cell lines were used for this study. A human breast
cancer epithelial cell line (MDA-MB- 435) was obtained from Tissue Culture Shared
Resource at Georgetown University, Lombardi Cancer Center.

Hybridoma cells (1C6)

were created in Dr. Tom Scott’s lab by fusion of spleen cells of immunized Balb/c mice
with SP2/0 myeloma cells. Bovine mammary epithelial cells (MAC-T) obtained from Dr.
Steve Ellis were also used (Huynh et al., 1991).
MDA-MB- 435 cells were thawed and initially cultured in Dulbecco’s Modified
Eagles

Medium

(DMEM)

containing

10%

bovine

growth

serum,

1%

penicillin/streptomycin, 1% amino acids, 11mg sodium pyruvate, and 4.0mM Lglutamine. The MAC-T cells were cultured in DMEM containing 10% bovine growth
serum, 1% penicillin/streptomycin, and 4.0mM L-glutamine. The 1C6 cells were cultured
with DMEM containing 10% bovine calf serum, 1% penicillin/streptomycin, 11mg
sodium pyruvate, 238mg HEPES, 100 ml 2-mercaptoethanol, and 4.0mM L-glutamine.
All cells were cultured in 75 cm² flasks and incubated at 37ºC in a humidified, waterjacketed CO2 (5%) incubator.

Lymph Node Preparation

Supramammary lymph nodes, collected at random, of both beef and dairy cows
were obtained from the Brown Packing facility in Gaffney, South Carolina. The isolated
lymph nodes were prepared according to one of two methods.
Lymph Node Preparation #1:
Initially lymph nodes were trimmed of fat with scissors and homogenized in a
food-grade blender with 10 ml of PBS for every five lymph nodes. The extract was then
centrifuged for 30 min at 26,500 × g. The supernatant was recovered and centrifuged
again for 30 min at 32,500 × g. Twenty ml of PBS were added to every 10 ml of extract
and filter sterilized with serum acrodisc (0.2µm) syringe filter. The extract was then heat
inactivated at 60ºC for 60 min. This lymph node preparation yielded a protein
concentration of 3.0 mg/ml.
Lymph Node Preparation #2:
Lymph nodes were trimmed of fat with scissors and processed through a Hobart
meat grinder until moderately homogenous. The homogenate was placed in freezer bags
at -80ºC for two days. The frozen lymph node homogenate was then crushed into small
pieces under liquid nitrogen in a mortar with pestle and lyophilized for approximately
seven days in a Virtis freeze dryer (SP Industries Inc, Warminster, PA) .

The

homogenate was then ground into a fine powder using a small food processor. Five
grams of the powder was weighed and mixed with PBS in a centrifuge tube to reach a
total weight of 50 grams. The solution incubated at room temperature for 20 min and
was then centrifuged for 15 min at 739 × g. The supernatant was removed and heat
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inactivated at 60ºC for 60 min. The solution was then centrifuged for 30 min at 7,000 × g
and filter sterilized (0.2 µm) with a Nalgene bottle top filter into a sterile container. This
preparation yielded a protein concentration of 27.0 mg/ml.

Protein Concentration

Protein concentration of the lymph node homogenate was determined using the
Warburg-Christian protein assay (Warburg and Christian, 1942). The homogenate was
diluted with nanopure water to a 1:10 dilution. One hundred microliters of the diluted
heat inactivated lymph node homogenate was added to a cuvette and read with an
Eppendorf Biophotometer spectrophotometer. Readings at A260 as well as A280 were
incorporated into the Warburg-Christian equation (C= 1.55 ×A280 – 0.76 ×A260). The
product of the equation was then multiplied by a dilution factor of 10 in order to obtain
the protein concentration.

MTT Assay

The MTT cell viability assay was used to assess the cellular activity of MDAMB-435 breast cancer epithelial cells exposed to lymph node extract supplementation in
culture medium.

MTT [(3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium

bromide), Sigma-Aldrich, St. Louis, MO] is a tetrazolium salt that undergoes reduction
(yellow to purple color change) in viable cells with active mitochondrial electron
transport systems. Cells were trypsinized with HyQ® Trypsin (0.25%) and centrifuged
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for 5 min at 400 × g. The supernatant was removed and the cells were re-suspended in
approximately 2 ml of medium. Cells were counted and added to a 96-well plate with
10,000 cells/well and held overnight in a CO2 incubator to adhere. The next day all
media was removed and the wells were rinsed two times with 100µl sterile PBS. The
appropriate media were then added to the wells without serum and incubated for 2 days
for the starvation period of the assay. Lymph node and BGS media were made at
different percentages with DMEM. 0, 1, 2, 2.5, 5, 10 and 20% media were added to the
plate at 100µl/well. Zero percent medium was made without serum or lymph node
extract. Lymph node preparation #1 was used for the MTT assay. In order to maintain
an equal protein concentration across treatments, BGS and non-heat inactivated lymph
node extract were diluted with PBS to the concentration of the heat inactivated lymph
node extract (3.0 mg/ml). For the 1% media, 1 ml of 3.0 mg/ml BGS and lymph node
extract (.03 mg/ml) was added to 99 ml of MD-MBA-435 media with the appropriate
components. For 2%: 2 ml was added to 98 ml (.06 mg/ml), 2.5%: 2.5 ml was added to
97.5 ml (.075 mg/ml), 5%: 5 ml was added to 95 ml (.15 mg/ml), 10%: 10 ml was added
to 90 ml (.3 mg/ml), and for 20%: 20 ml was added to 80 ml (.6 mg/ml). Four days later
50µl of MTT was added to each well four hours prior to end of incubation. The media
with MTT was then removed and 150µl of DMSO was added to each well. The plate
was placed on a shaker for approximately 15 minutes. Absorbance was obtained at
wavelengths 570 and 650 nm for each well. The O.D. by difference was recorded for
each well.
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CyQuant Assay

The CyQuant assay is used to determine the degree of DNA synthesis and cellular
proliferation through direct DNA staining with the CyQuant GR fluorescent dye.
CyQuant GR dye and 20x cell lysis buffer were purchased from Invitrogen (Carlsbad,
Cal). Serum starvation assay was run according to the protocol of MTT assay until
addition of CyQuant GR dye. Lymph node preparations #1 and #2 were used in the
CyQuant assay. MDA-MB-435 cells were treated with both preparations in two separate
CyQuant assays, and MAC-T and 1C6 cells were treated with only lymph node
preparation #2. Lymph node preparation #2 yielded the following protein concentrations:
1%: .27 mg/ml, 2%: .54 mg/ml, 5%: 1.35 mg/ml, 10%: 2.7 mg/ml, 20%: 5.4 mg/ml.
After 3 days with the different treatments the plate was inverted and blotted. The
CyQuant GR dye/lysis buffer contained 1.2 ml of 20x lysis buffer, 22.8 ml nuclease free
distilled water, and 60µl of CyQuant GR dye. Two hundred µl of dye/lysis buffer were
added to all wells. Plates were mixed gently and incubated for 2 to 5 min with covers to
protect from light. Plates were read on a BioTek Synergy HT plate reader at excitation of
480 and emission of 520 nm. Fluorescence intensity of each well was recorded.

Cell Growth Assays

To grow cells directly in lymph node media a direct suspension method
(adherence growth assay) as well as a modified adaptation method were used. Lymph
node extract from lymph node preparation #2 was used for the cell growth assays. Both
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assays used 10% lymph node medium with 1X DMEM as well as other medium
components appropriate for the specific cell line in culture. Bovine growth serum was
diluted with PBS in order to maintain all treatments at an equal protein concentration. A
protein concentration of 2.7 mg/ml (10% of 27 mg/ml lymph node extract stock) was
maintained throughout the assays. Diluted serum media was used as a positive control as
well as a 0% serum/lymph node medium as a negative control.
Adherence growth assay:
Cells were cultured to 100% confluency in regular media containing 10% serum
(BGS or BCS). Cells were then trypsinized and re-suspended in 2 ml of serum/lymph
node-free medium. Once cells were counted they were seeded at 10,000 cells/well in 24well plates with appropriate treatment media. Each treatment covered 12 wells. Five
hundred µl of treatment medium was added to each well. Cells adhered overnight and
were photographed once daily for 6 days using an inverted microscope fitted with a
digital camera. Plates were properly positioned on the microscope stage and pictures
were taken with the 40X objective.
Adaptation growth assay:
Cells were cultured to nearly 100% confluency in standard medium containing
non-diluted 10% serum (approximately 6.6 mg/ml of BGS or BCS) in a 25 cm² flask as
well as a six well plate. Once confluent, all media were removed and 25% of 2.7mg/ml
lymph node media was added along with 75% regular media with BGS. Once medium
was pulled off of the well of the six-well plate, Azure II dye was added and photos were
taken.

Photos of the cells were also taken without Azure II dye staining.

Day 1

represents confluency, Day 2 is 25% lymph node media, Day 3 is 50% lymph node
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media, Day 4 is 75% lymph node media, and Day 5 is 100% lymph node media. For the
MDA-MB-435 cells as well as the MAC-T cells trypsin was added on Day 5 and cells
were re-seeded into a new flask. 1C6 cells were scraped and re-seeded into a new flask.
Cells were incubated overnight to adhere. This was done to evaluate the “adapted” cells
ability to re-adhere with only lymph node medium in culture. Photos were taken of the
newly seeded flasks without Azure II dye. Cell growth in the flasks and plates was
assessed through visual analysis. Detachment of cells resulting in floating cells, cellular
debris, and standard attachment and spreading out, were characteristics of cells observed
in the cultures.

Apoptosis Assay

To determine if cell death was due to apoptosis during the growth assays, DNA
extraction and gel electrophoresis were performed on 4 differently treated groups of
MDA-MB-435 cells. Cells were plated 100,000 cells/well on 6 well plates. The first
group went through a starvation period of 2 days before lymph node medium (2.7 mg/ml)
was added. The second group was plated and allowed one day to adhere before lymph
node medium was added. The third group contained cells that were adapted to lymph
node medium and were plated the day of lymph node media addition. The fourth group
of cells was plated the day of lymph node medium addition. Cells were trypsinized,
scraped, and removed from wells at 0, 2, 4, 8, and 24 h time points post addition of
lymph node medium. Cells were centrifuged at 13,000 x g for 5 min. DNA extraction
was performed at each time point following the DNeasy Qiagen protocol. Pellets were
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re-suspended in 200µl PBS and 20µl of proteinase K (600 mAU/ml) as well as 4µl of
RNase A (7,000mAU/ml) were added. Two hundred µl of buffer AL (lysis buffer) was
added and cells were incubated at 56°C for 10 min. Ethanol was added and sample was
vortexed. The entire mixture was added to DNeasy Mini spin columns and centrifuged
twice at 6000 x g. Buffer was added and solution was centrifuged for 3 min at 20,000 x
g. One hundred µl of Buffer AE was added to columns and centrifuged twice for 1 min
at 6000 x g for the elution of DNA.
DNA content for each sample was determined with a spectrophotometer in order
to obtain DNA concentrations. The lowest concentration obtained dictated the addition
of 100 ng of DNA per lane in an agarose gel. One kilobase (kb) and 100 base pair (bp)
ladders were added at 6µl/well (ProMega benchtop ladders) in assigned lanes of each gel.
One percent agarose gel with 0.5X TBE running buffer was used. Samples were loaded
and the gel ran for 1 h at 126 volts.

Protein Gel

BGS as well as lymph node preparation #2 were run on a SDS PAGE (sodium
dodecyl sulfate polyacrylamide gel electrophoresis) 12% Tris/HCl gel. Samples were
denatured with SDS PAGE sample buffer (100 mM Tris, 2% SDS, 5% ßmercaptoethanol, and 15% glycerol) and boiled for 5 minutes. Five µl of each sample
were loaded on a 30 µg/ml basis with GelCode® Blue Stain Reagent (Pierce
Biotechnology, Inc., Rockford, IL) along with 2 Biorad Precision Plus Protein Dual Color
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Standards (Bio-Rad Laboratories, Inc., Hercules, CA). The gel was run at 120 volts for 1
h.

Statistical analysis

MTT and CyQuant assay data were analyzed using the SAS program (Statistical
Analysis System, Cary, NC). The MTT and CyQuant experiments were completely
random designs with factorial arrangements of treatments. The main effects were media
supplements (BGS vs. LN), and concentrations of supplements, with the interaction being
media supplement by concentration of supplement. The experimental model was as
follows: Yijk = µ + αi + βj + (αβ)ij + eijk where, µ= overall mean, αi = ith level of the media
supplement, βj = jth concentration of the media supplement, (αβ)ij = the interaction of the
ith level of media supplement with the jth concentration of supplement, and eijk = random
error. Variability between treatments was determined through an ANOVA procedure
using PROC GLM with an α level of 0.05. Differences between treatment means were
further separated by least-significant differences (LSD).
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4. RESULTS
MTT assay with MDA-MB-435 cells

MDA-MB-435 cells underwent a serum starvation period of 2 days and a medium
re-supplementation treatment period of 4 days. All media re-supplementation treatments
were based on an equal protein basis (3.0 mg/ml), and MTT was added on the fourth day
of treatment to assess all cell viability. Results in Figure 1 are expressed as stimulation
indices (S.I. = O.D. supplemented media/O.D. 0% supplemented media) of cell viability
assessed through MTT reduction. A stimulation index above 1 is representative of cell
viability greater than the control group (0% serum or lymph node extract). Figure 1
shows that heat inactivated lymph node extract supports significantly greater cell viability
at 10 and 20% supplementation (.3 and .6 mg/ml protein) than observed for both BGS
and non-heat inactivated lymph node extract (p<.0001). 20% heat inactivated lymph
node extract in fact supports cell viability even greater than it does at 10%. The heat
inactivated extract is the only treatment with a S.I. above 1 at every supplement
concentration. As low as 1% (.03 mg/ml) heat inactivated lymph node extract can
support cell viability better than the traditional BGS supplementation at the same
percentage. 1% heat inactivated lymph node extract also supports viability better than
10% and 20% BGS. BGS does support cell viability at 2, 2.5 and 5% supplementation,
with marginal support at 10%. Non-heat inactivated lymph node extract does not sustain
cell viability at any concentration. Non-heat inactivated lymph node extract inhibits cell
viability as evidenced by the much lower S.I. values compared to the control point of 0%

supplementation (dashed line).

CyQuant assay with MDA-MB- 435, MAC-T, and 1C6 cells

MDA-MB-435 cells underwent the same serum starvation assay as with the MTT
assay. CyQuant assays were run with both 3.0 and 27 mg/ml lymph node extracts. The
results are expressed as a proliferation index (P.I. = fluorescence intensity of
supplemented media/fluorescence intensity of 0% supplemented media). A proliferation
index above 1 (indicated by the dashed line) is indicative of cell proliferation greater than
the control group (0% serum or lymph node extract). Figure 2 represents proliferation of
MDA-MB-435 cells with lymph node preparation #1 (3.0 mg/ml). This figure shows that
the heat inactivated extract supports proliferation better than both non-heat inactivated
lymph node extract and BGS at all percentages of supplementation. Bovine growth
serum best supports cell proliferation at 2.5% (.075 mg/ml protein), followed by a decline
in proliferation from 5 to 20%. One percent heat inactivated lymph node extract supports
cell proliferation better than 5, 10, and 20% supplementation with BGS. In concurrence
with Figure 1, a lower protein concentration of .03 mg/ml (1%) heat inactivated lymph
node extract supports cells better than the standard BGS supplement at the highest three
protein concentrations tested. Non-heat inactivated lymph node extract does not support
cell proliferation at any percentage as evidenced by the apparent inhibitory level of cell
proliferation demonstrated in Figure 2.
The CyQuant assays with lymph node preparation #2 did not include non-heat
inactivated lymph node extract because of the evident inhibitory effects observed with
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preparation #1. MDA-MB-435, MAC-T, and 1C6 cells were cultured with lymph node
preparation #2. Figure 3 illustrates the effects of lymph node preparation #2 (27 mg/ml)
lymph node extract on MDA-MB-435 cells. The proliferation of cells cultured with BGS
and heat inactivated lymph node extract is significantly different (P<.0001) at all
percentages except 1% supplementation (.27 mg/ml protein).

BGS maintains cell

proliferation at or slightly above the 0% control from 1-5%, with a slight drop at 10 and
20% supplementation (2.7 and 5.4 mg/ml protein). The heat inactivated lymph node
extract maintains cell proliferation below the 0% control from 1-5% supplementation;
however, MDA-MB-435 cells exhibit a dramatic increase in proliferation with heat
inactivated lymph node extract at 10 and 20% supplementation. This latter effect of heat
inactivated lymph node extract resulted in a significant supplementation by percent
supplementation interaction (P<.0001).
MAC-T cell proliferation is significantly different between BGS and heat
inactivated lymph node extract cultured cells at 1, 10, and 20% supplementations (Fig 4).
BGS maintains cell growth at or slightly above the 0% control throughout all percent
supplementations.

Heat inactivated lymph node extract supports cell proliferation

slightly above the 0% control from 1- 5% supplementation. Similar to the results with
the MDA-MB-435 cells, MAC-T cells have a dramatic increase in proliferation at 10 and
20% supplementation leading to a significant interaction effect (P<0.0001).
1C6 cell proliferation is significantly different between BGS and heat inactivated
lymph node extract at all percent supplementations (P<0.0001) (Fig 5). BGS maintains
cell proliferation slightly below the 0% control at 1, 2, 5, and 10% supplementations, and
right at the 0% control level at 20%. Heat inactivated lymph node extract maintains cell
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proliferation at or above the 0% control at 1, 2, and 5% supplementations. In agreement
with MDA-MB-435 and MAC-T cells, 1C6 cells also have a dramatic increase in
proliferation at 10 and 20% supplementation and a significant interaction for
supplementation source and percent supplementation (P≤0.001).

Adherence growth assays

MDA-MB-435 cells as well as MAC-T and 1C6 cells were cultured in respective
treatment media. Media without serum or lymph node extract were used as negative
controls (0%).

Media with 10% bovine growth serum diluted to an equal protein

concentration (2.7 mg/ml) were positive controls (BGS). Media were also made with
10% lymph node extract (LN). The photos were visually assessed to rate cell growth and
adhesion. The adherence assay was also attempted using the 1C6 cells, however, the cells
failed to grow in any treatment. Photos were not taken due to inadequate visibility of
cells. On Day 1, with 0% supplementation, MAC-T cells did not appear to be actively
proliferating, but did illustrate minimal adherence and spreading (Fig 6). Day 1 with
BGS, MAC-T cells illustrated normal spreading, unlike cells with the LN which did not
adhere or spread and did not have a healthy appearance (Fig 6). Days 2 and 3 continue
the trend observed on Day 1 with the MAC-T cells and respective treatments (Fig 7 and
8). By Day 4 the LN treated cells had crenated membranes and cell debris was present
(Fig 9). On Day 4 the MAC-T cells with BGS continued to grow to confluency, and the
0% serum cells were not proliferating or spreading out (Fig 9). Days 5 and 6 illustrated
similar results as Day 4, with confluency (BGS), cell debris and apparent death (LN), and
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a halt in proliferation (0%) (Fig 10 and 11). The cell membranes of the lymph node
treated cells appeared picnotic compared to BGS and 0% supplemented cells at any time
point. The MDA-MB-435 cells showed a trend similar to the MAC-T cells with all
treatments. Day 1 is difficult to decipher because of the difference in magnification
(100X vs. 400X) which was done to capture the amount of cells rather than specific
morphology at that point (Fig 12). On Day 2 MDA-MB-435 cells showed 0% and BGS
supplemented cultures had cells beginning to spread out (0% very minimally), with LN
cells already presenting shriveled, crenated membranes and unadhered cells (Fig 13).
Day 3 illustrates similar results as Day 2 for LN and 0% cells, with increased confluency
of BGS supplemented cells (Fig 14). On days 4 through 6 MDA-MB-435 cells showed
proliferation of cells with BGS, rounded clustered cells (halted growth) with 0%
supplementation, and cell debris along with apparent cellular death with LN (Fig 15-17).

Adaptation growth assays

Photos were taken of Azure II dyed MDA-MB-435, MAC-T, and 1C6 cells in 6well plates (Fig 18, 20, and 22) as well as non-dyed cells in 25cm² flasks (Fig 19, 21, and
23). Day 1 for all cell lines represents confluency without any LN media. Day 2
represents 25% of 10% LN media addition, Day 3: 50% of LN media addition, Day 4:
75% LN media addition, Day 5: 100% of 10% LN medium. Day 6, with the different cell
lines in the flasks, represents cells after trypsinization or scraping. MAC-T cells in the
plate and flask (up to Day 5) maintained confluency and normal morphology (Fig 18 and
19: i-v). On Day 6, after trypsinization, the cells did not re-adhere and cell debris is
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present (Fig 19vi). The MDA-MB-435 cells followed the same trend as the MAC-T cells
with confluency in the plate and flask up to Day 5 (Fig 20 and 21: i-v). Day 6, after
trypsinization, did not show any adherence of cells, and the few floating cells appeared
dead (Fig 21vi). Cell debris was not as prevalent as it was with the MAC-T cells. 1C6
cells did not maintain confluency like the MDA-MB-435 and MAC-T cells. Days 1 and
2 cells are confluent, but with 50% lymph node media addition on Day 3, 1C6 cells seem
to have a change in morphology as well as a decrease in confluency (Fig 22 and 23). The
cells are rounding up by Day 3 and all have a picnotic membrane appearance. 1C6 cells
continue to change morphology on Days 4 and 5 with a significant decrease in
confluency on Day 5 with the full 10% lymph node extract in the medium (Fig 22 and
23). When 1C6 cells were scraped and re-seeded, these cells were unable to adhere. Few
remained floating and appeared dead (Fig 22vi).
Adaptation seemed to have been acquired with the MDA-MB-435 and MAC-T
cells considering there were no apparent dead cells on Day 5 (Fig 18v-21v), but once
cells were trypsinized and re-seeded they were unable to adhere and ultimately did not
survive even following an adaptation phase (Fig 19 and 21vi). 1C6 cells illustrated a lack
of adaptation by Day 3 (Fig 22 and 23iii).
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Apoptosis Assay

Apoptosis can be determined on a DNA gel by the appearance of 200 bp multiples
of DNA fragments. Figure 24 (0 and 2 h time points), Figure 25 (4 and 8 h time points),
and Figure 26 (24 h time point) are photographs of 1% agarose gels run with DNA
extracted from MDA-MB-435 cells under different conditions. Cells starved for two
days and cultured with 10% lymph node extract (2.7 mg/ml) (Lanes 2 and 8), cells
adhered overnight and cultured with 10% lymph node extract (Lanes 3 and 9), lymph
node extract adapted cells cultured directly into 10% lymph node extract (Lanes 4 and
10), and cells cultured directly into 10% lymph node extract (Lanes 5 and 11). Figure 23
is only one time point (24 h); therefore the same conditions apply but only for lanes 2
through 5. DNA standards are run in Lanes 1(1kb) and Lane 6(100bp). Results obtained
from gels at all time points do not indicate apoptosis occurred; however, it was apparent
from the culture adaptation experiment that cells were not surviving under particular
supplementation and treatment conditions.

Protein Gel

Figure 27 illustrates protein bands from both BGS and lymph node preparation #2
extract. Lanes 1 and 4 represent protein standards. BGS (Lane 2) has very heavy
staining bands at 50 kD and above, which is most likely immunoglobulin heavy chains
and albumin. Lymph node extract (Lane 3) has a less intense albumin band, as well as an
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array of bands spanning the length of the standards. There are obvious differences in
protein composition between BGS and the lymph node extract based on this protein gel.
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Figure 1. Stimulation index of heat-inactivated lymph node extract (LN)
(white), non- heat inactivated LN (striped), and BGS (black) on MDA-MB435 cells after a serum starvation assay (MTT). *Mean S.I. significantly
different (P≤ 0.05) from respective mean for heat inactivated LN.
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Figure 2. Proliferation index of MDA-MB-435 cells with heat-inactivated
lymph node extract (LN) (white), non-heat inactivated LN (striped), and
BGS (black). Cells assessed through CyQuant assay. *Mean P.I.
significantly different (P≤ 0.05) from respective mean for heat inactivated
LN.
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Figure 3. Proliferation index of MDA-MB-435 cells with heat-inactivated lymph
node extract (LN) (white) and BGS (black). Cells assessed through CyQuant
assay. *Mean P.I. significantly different (P≤ 0.05) from respective mean for heat
inactivated LN.
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Figure 4. Proliferation index of MAC-T cells with heat-inactivated lymph
node extract (LN) (white) and BGS (black). Cells assessed through CyQuant
assay. *Mean P.I. significantly different (P≤ 0.05) from respective mean for
heat inactivated LN.
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Figure 5. Proliferation index of 1C6 cells with heat-inactivated lymph node
extract (LN) (white) and BGS (black). Cells assessed through CyQuant
assay. *Mean P.I. significantly different (P≤ 0.05) from respective mean for
heat inactivated LN.
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Figure 6. Photomicrographs of 1 day cultures of MAC-T cells cultured in media
supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm.
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Figure7. Photomicrographs of 2 day cultures of MAC-T cells cultured in media
supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm.
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Figure 8. Photomicrographs of 3 day cultures of MAC-T cells cultured in media
supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm.

42

Figure 9. Photomicrographs of 4 day cultures of MAC-T cells cultured in media
supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm
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Figure 10. Photomicrographs of 5 day cultures of MAC-T cells cultured in media
supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm.
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Figure 11. Photomicrographs of 6 day cultures of MAC-T cells cultured in media
supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm.
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Figure 12. Photomicrographs of 1 day cultures of MDA-MB-435 cells cultured
in media supplemented with 0% (0), 10% bovine growth serum (BGS), or 10%
heat-inactivated lymph node extract (LN). White line = 50 µm.

46

Figure 13. Photomicrographs of 2 day cultures of MDA-MB-435 cells cultured
in media supplemented with 0% (0), 10% bovine growth serum (BGS), or 10%
heat-inactivated lymph node extract (LN). White line = 20 µm.
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Figure 14. Photomicrographs of 3 day cultures of MDA-MB-435 cells cultured
in media supplemented with 0% (0), 10% bovine growth serum (BGS), or 10%
heat-inactivated lymph node extract (LN). White line = 20 µm
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Figure 15. Photomicrographs of 4 day cultures of MDA-MB-435 cells cultured
in media supplemented with 0% (0), 10% bovine growth serum (BGS), or 10%
heat-inactivated lymph node extract (LN). White line = 20 µm.
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Figure 16. Photomicrographs of 5 day cultures of MDA-MB-435 cells cultured in
media supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm
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Figure 17. Photomicrographs of 6 day cultures of MDA-MB-435 cells cultured in
media supplemented with 0% (0), 10% bovine growth serum (BGS), or 10% heatinactivated lymph node extract (LN). White line = 20 µm.
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Figure 18. Photomicrographs over a 5 day period with
cultures of MAC-T cells cultured in a 6 well plate with
media supplemented with10% heat-inactivated lymph node
extract (LN). White line = 20 µm.
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Figure 19. Photomicrographs over a 6 day period with
cultures of MAC-T cells cultured in a flask with media
supplemented with10% heat-inactivated lymph node
extract (LN). Day 6 represents trypsinization. White line
= 20 µm..
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Figure 20. Photomicrographs over a 5 day period with
cultures of MDA-MB-435 cells cultured in a 6 well plate
with media supplemented with10% heat-inactivated lymph
node extract (LN). White line = 20 µm.
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Figure 21. Photomicrographs over a 6 day period with
cultures of MDA-MB-435 cells cultured in a flask with
media supplemented with 10% heat-inactivated lymph
node extract (LN). Day 6 represents cells after
trypsinization. White line = 20 µm.
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Figure 22. Photomicrographs over a 5 day period with cultures
of 1C6 cells cultured in a 6 well plate with media supplemented
with 10% heat-inactivated lymph node extract (LN). White line
= 20 µm.
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Figure 23. Photomicrographs over a 6 day period with
cultures of 1C6 cells cultured in a flask with media
supplemented with10% heat-inactivated lymph node
extract (LN). Day 6 represents trypsinization. White
line = 20 µm.
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Figure 24. DNA extracts from 0 and 2 h time points run on
a 1% agarose gel. Lanes 1 and 7: 1Kb ladder, Lanes 6 and
12: 100 bp ladder, Lanes 2 and 8: Cells starved for two days
and cultured with 10% lymph node extract, lanes 3 and 9:
Cells adhered overnight and cultured with 10% lymph node
extract, Lanes 4 and 10: Lymph node extract adapted cells
cultured directly into 10% lymph node extract, Lanes 5 and
11: Cells cultured directly into 10% lymph node extract.

58

10,000
8,000
6,000
5,000
4,000
3,000
2,500
1,500

1,500
1000

1000
900
800
700

750

600
500

500
300
200

250

100

Lane

1

2

3 4 5

6

7 8 9 10 11 12

Figure 25. DNA extracts from 4 and 8 h time points run on
a 1% agarose gel. Lanes 1 and 7: 1 Kb ladder, lanes 2 and 8:
Cells starved for two days and cultured with 10% lymph
node extract, Lanes 3 and 9: Cells adhered overnight and
cultured with 10% lymph node extract, Lanes 4 and 10:
Lymph node extract adapted cells cultured directly into 10%
lymph node extract, Lanes 5 and 11: Cells cultured directly
into 10% lymph node extract, lanes 6 and 12: 100 bp ladder.
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Figure 26. DNA extracts from 24 h time point run on a 1%
agarose gel. Lane 1: 1Kb ladder, Lane 3: Cells starved for
two days and cultured with 10% lymph node extract, Lane
4:Cells adhered overnight and cultured with 10% lymph
node extract, Lane 5: Lymph node extract adapted cells
cultured directly into 10% lymph node extract, Lane 6: Cells
cultured directly into 10% lymph node extract, Lane 8: 100
bp ladder.
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Figure 27. SDS PAGE analysis of BGS and lymph node extract from lymph
node preparation #2. Lanes 1 and 4: Protein standards, Lane 2: BGS, Lane 3:
Lymph node extract.
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5. DISCUSSION

The question of whether or not substitution of the standard bovine sera
supplementation with lymph node extract can support and maintain the growth of three
different cell lines was addressed with a set of experiments. The MTT assay was used in
order to determine cell viability, where MTT is reduced to purple formazan in the
mitochondria of living cells (Mosmann, 1983). Essentially, the assay is a measurement
of active mitochondrial reductase enzymes. The CyQuant assay directly measures the
cellular DNA content. The CyQuant dye binds to the nucleic acids of the lysed cells, and
fluorescence intensity of the dye is read (Jones et al., 2001).

This assesses cell

proliferation and cell numbers. Both of these reagents were used in serum starvation
assays to assess the potential growth enhancing effects of the lymph node extract in
culture media.
In the present assays the cells were starved over a period of 2 days, and the lymph
node extract was then added for 3-4 additional days of culture.

MTT results are

presented as a stimulation index in order to determine cell viability above the negative
control (0% supplementation). Lymph node preparation #1 (3.0 mg/ml) was used for the
MTT assay. The non-heat inactivated lymph node extract did not support cell viability at
any percent supplementation, and actually appeared to inhibit the cells. This inhibition
could be due to complement proteins in the extract that can be inactivated with heat,
which was done with a matched extract. BGS and other bovine sera used in cell culture

are routinely heat inactivated to remove complement, which is a heat sensitive factor
(Carroll, 2004). The complement could be lysing the cells, thereby contributing to
decreased viability. Complement factors can be released from macrophages stimulated
by IL-6, TNF-α and interferon-γ (Carroll, 2004); all of which are found in the lymph
node environment (Willard-Mack, 2006).
The significant support of cell viability at 10 and 20% with the heat inactivated
extract was far beyond the support of BGS or non-heat inactivated extract at any
percentage. The heat inactivated lymph node extract supported cell viability more than
the 0% control at each percent supplementation, whereas BGS only supported viability
above the 0% control at 2, 2.5, and 5% supplementation (with marginal support at 10%)
(Figure 1). The drop in viability at 20% with BGS is difficult to understand considering at
this supplementation the protein concentration would be the most concentrated.
However, twenty percent in this assay was still significantly lower than what would
traditionally be in cell culture media supplemented with BGS which can be as high as 66
mg/ml (20% of 66mg/ml: 13.2 mg/ml vs. 20% of 3.0 mg/ml: .6 mg/ml).
Similar to the MDA-MB-435 cell MTT results with lymph node preparation #1,
the heat inactivated lymph node extract supports cell proliferation above the control at
each percent supplementation (Figure 2). Although the best support is at 20%
supplementation with the heat inactivated extract, 1-10% supplements were not
significantly lower than the 0% control, suggesting that a difference in .57 mg/ml of
protein (.6 mg/ml 20%- .03 mg/ml 1%) did not result in a dramatic change in
proliferation. BGS supported cell growth best at 2.5% supplementation and was followed
by a decline in proliferation with serum supplementation from 5 to 20%. Again, this is
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difficult to comprehend based upon the standard protein concentration of BGS. Non-heat
inactivated extract, in concurrence with the MTT results, did not support proliferation at
any percent supplementation.
Lymph node preparation #2 was used for CyQuant assays with MDA-MB-435,
MAC-T, and 1C6 cells. This preparation yielded a much higher protein concentration
(27 mg/ml) compared to lymph node preparation #1 (3.0 mg/ml). The increase in protein
content (due to the more refined method of preparation) was the deciding factor for which
extract to continue using in the assays. The process involved in making lymph node
extract #2 is also a more efficient system that may be used if this product was to be mass
produced. MAC-T and 1C6 cells were introduced with this extract in order to obtain
results from a variety of cell lines. MAC-T bovine mammary epithelial cells are a
comparable cell line to the MDA-MB-435 human breast epithelial cell line. A hybridoma
cell line (1C6) was introduced because of its immunological nature (B cell fused with a
myeloma cell) which should respond to factors present in a lymph node.
All three cell lines exhibited a dramatic increase in cell proliferation at 10 and
20% lymph node extract supplementation.

MAC-T cell numbers increased to

proliferation indices of greater than 6 but less than 7, whereas MDA-MB-435 cells
increased to greater than 3.5 but less than 4.0. 1C6 cells reach the highest proliferation
indices (greater than 7 but less than 8) compared to MDA-MB-435 and MAC-T cells.
The MDA-MB-435 cells are characterized as being more aggressive compared to the
MAC-T and 1C6 cells, therefore stimulating their already accelerated growth rate did not
illustrate as dramatic a difference. All three cell lines with #2 lymph node preparation
reached higher proliferation indices compared to MDA-MB-435 CyQuant data with
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lymph node preparation #1 (greater than 1.2 but less than 1.4) (Fig 2). This would be due
to the significant difference in protein concentration and composition of the two lymph
node preparations. With lymph node preparation #1 going from 5 to 10% is only a .15
mg/ml difference in protein, and 10 to 20% is only a .3 mg/ml difference. Comparing
this to lymph node preparation #2, 5 to 10% is a 1.35 mg/ml difference, and 10-20% is a
2.7 mg/ml difference. The cell maintenance with BGS was similar, supporting all cell
lines below or slightly above the 0% control. BGS had an expected maintenance effect
on all three cell lines, stabilizing cells between a 1.0-1.5 stimulation index.

Heat-

inactivated lymph node extract provided a type(s) of stimulatory or mitogenic effect,
which resulted in an accelerated growth rate for the cells. This is dramatically illustrated
with lymph node preparation #2 at 10 and 20% with the three different cell lines (Fig 3,
4, and 5). This accelerated effect was not as apparent with lymph node preparation #1.
The difference in protein composition offers a credible explanation for the differences in
results produced by the different preparations.
The apparent accelerated effect the heat inactivated lymph node extract has on the
cells may be due to a number of growth promoting factors present in the extract. Figure
27 illustrates the protein differences between BGS and the lymph node extract.

A

variety of cytokines (IL-6, IL-13, IL-4, IL-12, IL-10) are present in lymph nodes and may
provide the proliferative effect seen with the cells (Zou et al. 1996). IGF’s and PGE2
have been detected in the lymph draining the supramammary lymph node and may also
be contributing to the cell growth (Lacasse et al., 1996). Although growth factors are
present in BGS, the amount may not be sufficient enough to provide a stimulatory
response, rather only provide maintenance of cell growth. IGF-I and II have both been
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identified in BGS (Honegger and Humbel, 1986). There may be similarities in protein
content between bovine serum and lymph node extract, but the actual concentrations of
these growth promoting factors may define stimulation versus maintenance.
The ability to culture cells in the lymph node supplemented media over an
extended period of time without BGS supplementation was the eventual objective in
deciding whether or not to use the extract as a substitute in cell media. Two different
growth assays were used to determine cell survival in culture.
The results of the adherence growth assays do not show promise for the
substitution of 10% or greater lymph node extract in culture media. Cell lines did not
adhere and appeared to be dying within the first day in culture. The adherence growth
assay was not a gradual addition of the new media over time, rather an abrupt change.
This overwhelming new condition may have been too different for the cells to adapt to all
at once. A less aggressive approach of introducing the lymph node extract in the media
was attempted in the adaptive growth assay.
The adaptive growth assay was performed with all three cell lines (MDA-MB435, 1C6, and MAC-T). Different methods of adaptation were attempted, following
Invitrogen protocol (2003) for adapting cells to serum-free media. Due to the cells
inability to re-adhere once trypsinized with the lymph node extract, a new method was
developed.

Rather than continuing to passage cells with different percent

supplementations of the lymph node extract, cells remained adhered and were not
passaged until 100% adaptation had been achieved. As the lymph node extract was
gradually added to the media with BGS still present in reduced percentages the cells
appeared to adapt fairly well. The 1C6 cells did not thrive as well as the MAC-T or
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MDA-M-435 cells and began to round up at day 3 (Fig 22 and 23iii). The morphology of
the 1C6 cells changed, with a loss of their round full membranes and a more crenated
membrane appearance. When all three lines were trypsinized or scraped and re-seeded
into a new flask they were unable to adhere and appeared to die. The inability to adhere
may be due to the ‘stimulation overload’ presented by the lymph node extract. Cells,
such as human corneal epithelial cells, have been shown to grow without serum present
in medium (Bednarz et al., 2001). If cells can maintain growth without serum, the
addition of lymph node extract might provide a greater amount of growth promoting
factors that would favor excessive mitogenesis rather than maintenance of steady-state
growth. Cells exposed to the lymph node extract are being stimulated with more and
different protein than the cells are normally accustomed to in BGS. The abundance of
proteins in the extract may be offering too many mitogenic signals at one time for the
cells to respond with adherence. Weber et al. (1999) observed mitogenic activity with
bovine mammary extracts on bovine mammary epithelial cells. Cell growth with the
mammary extract was 2 times higher than the growth with IGF-I alone. This potent
mitogenic response was not seen with IGF-I or FBS alone. IGF-I supported cell growth
significantly better than basal medium (0%), even at 3 µg/ml, implying that low
concentrations of growth factors can support/sustain cell growth. While the high percent
supplementations with the lymph node extract are mitogenic, lower percent
supplementations might sustain cells in culture with sub-mitogenic concentrations of
growth factors.
Apoptosis is defined as ‘programmed cell death’ (Glinsky, 1997). Cells can die
through this process or cell death can occur nonspecifically through necrosis. The
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agarose gel was run to determine if apoptosis had occurred in cells cultured in the
presence of the lymph node extract under different circumstances. The cell growth
assays, as well as the MTT and CyQuant serum starvation assays, suggest that if the cells
were adhered before the extract was added; the cells would survive. Cells evaluated by
the apoptosis assay that were given time to adhere were expected to survive. Once the
lymph node media was added, as early as 2 h, the starved cells had a notably different
appearance compared to the non-starved adhered cells. The starved cells maintained their
standard spread-out ‘healthy’ glow, whereas the non-starved cells began to round up and
displayed unhealthy membranes with dark granules present. The cells directly suspended
in the lymph node extract (adapted and non-adapted) did not adhere at any point, did not
have round full membranes, and eventually appeared dead. Although apoptosis was not
detected there was definitely a change in appearance and apparent health of the cells in
culture.
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6. CONCLUSIONS AND FUTURE WORK

Combining results from all experiments has allowed for a degree of insight into
understanding the effects of the lymph node extract on cells. The CyQuant data with all
three cell lines illustrated a stimulatory response with 10 and 20% supplementation
observed with the serum starvation assays. From these results 10% supplementation was
chosen to culture the cells in order to obtain visual results of cell growth. Twenty percent
could have been used, but 10% was chosen because of the standard use of 10% BGS in
cell culture, and also because of the minimal difference in effect between 10 and 20%.
Directly culturing cells in lymph node extract did not result in cell adherence, potentially
due to ‘over-stimulation’ by the extract which favored proliferation of cells rather than
promoting adherence for cell maintenance. The extreme stimulatory response seen in the
CyQuant data helps support this conclusion. Adding lymph node extract gradually to the
cells once they had already adhered illustrated results seen from the CyQuant data, with
MDA-MB-435 and MAC-T cells proliferating to the extent of overgrowing the space in
the wells/flasks. 1C6 cells may not have responded as well because of their specific cell
type and morphology. These cells do not spread out or adhere as tightly as the MDAMB-435 or MAC-T cells. They also do not share the characteristic of an epithelial cell
with the MDA-MB-435 or MAC-T cells. Once the cells were trypsinized they were
unable to adhere, agreeing with results obtained from the adherence growth assay.
Bovine serum is a widely used growth supplement in cell culture. Bovine growth serum

can cost as much as $96 for 500 ml (Fisher Scientific), and for labs conducting large
amounts of cell culture the expense of BGS can get extremely high. The ability to
substitute serum with something more affordable and easy to obtain that supports cells as
well, if not better than serum, would be optimum.
Potential research experiments with the bovine supramammary lymph node
extract are countless. This study was an initial attempt to understand the potential use of
the extract in culture. Although cells cannot be cultured and passaged with 10% heat
inactivated lymph node extract they may thrive at a lower concentration. The stimulatory
effect the extract has at 10 and 20% may be too potent for maintaining cells in culture.
Attempts to culture cells in the extract at lower concentrations are required to fairly
assess the usefulness of the extract. If a lower concentration successfully sustains cell
growth this could be advantageous in the areas of cost and preparation.

Selected

fractions of the extract may also offer different results. In order to rid the extract of
factors that may inhibit growth, fractionation of the extract should be performed and
tested on different cell lines.

Once different fractions are isolated, cell growth

characterization under the influence of these proteins may be performed.
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